Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.
dc.contributor.author | Ntoumi, F. | |
dc.contributor.author | Petersen, E. | |
dc.contributor.author | Mwaba, P. | |
dc.contributor.author | Aklillu, E. | |
dc.contributor.author | Mfinanga, S. | |
dc.contributor.author | Yeboah-Manu, D. | |
dc.contributor.author | Maeurer, M. | |
dc.contributor.author | Zumla, A. | |
dc.date.accessioned | 2022-08-01T15:43:55Z | |
dc.date.available | 2022-08-01T15:43:55Z | |
dc.date.issued | 2022 | |
dc.description | Research Article | en_US |
dc.description.abstract | Objectives: Investments into ‘Blue Skies’ fundamental TB research in low- and middle-income countries (LMICs) have not been forthcoming. We highlight why blue skies research will be essential for achieving global TB control and eradicating TB. Methods: We review the historical background to early TB discovery research and give examples of where investments into basic science and fundamental ‘blue skies research’ are delivering novel data and ap- proaches to advance diagnosis, management and holistic care for patients with active and latent TB in- fection. Findings: The COVID-19 pandemic has shown that making available adequate funding for priority invest- ments into ‘Blue skies research’ to delineate scientific understanding of a new infectious diseases threat to global health security can lead to rapid development and rollout of new diagnostic platforms, treat- ments, and vaccines. Several advances in new TB diagnostics, new treatments and vaccine development are underpinned by basic science research. Conclusions: Blue Skies research is required to pave the way for a personalized medicine approach for management of TB and other Respiratory Tract Infections and preventing long-term functional disability. Transfer of skills and resources by wealthier nations is required to empower researchers in LMICs countries to engage in and lead Blue Skies research. | en_US |
dc.identifier.other | https://doi.org/10.1016/j.ijid.2022.03.012 | |
dc.identifier.uri | http://ugspace.ug.edu.gh/handle/123456789/38218 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Tuberculosis | en_US |
dc.subject | Research | en_US |
dc.subject | basic science | en_US |
dc.subject | fundamental | en_US |
dc.subject | blue skies research | en_US |
dc.title | Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections. | en_US |
dc.type | Article | en_US |